mResvia Respiratorisches-Synzytial-Virus (RSV) Vakzin 0.10 mg/ml
mResvia Respiratorisches-Synzytial-Virus (RSV) Vakzin 0.10 mg/ml is a medicine authorised by Swissmedic under authorisation number 69995. The authorisation holder is Moderna Switzerland GmbH. The medicinal product code is Vaccines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 17 April 2025 and the authorisation is limited until 16 April 2030. ATC code J07BX05 places the medicine in the group Vaccines.
| Authorisation number | 69995 |
|---|---|
| Name | mResvia Respiratorisches-Synzytial-Virus (RSV) Vakzin 0.10 mg/ml |
| Full name | mResvia Respiratorisches-Synzytial-Virus (RSV) Vakzin 0.10 mg/ml, Injektionsdispersion |
| Authorisation holder | Moderna Switzerland GmbH |
| Medicinal product code | Vaccines |
| Dispensing category | B · Prescription only |
| ATC code | J07BX05 |
| First authorisation | 17 April 2025 |
| Authorisation validity | 16 April 2030 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | mResvia Respiratorisches-Synzytial-Virus (RSV) Vakzin 0.10 mg/ml, Injektionsdispersion | B | 17 April 2025 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Fertigspritze(n) | J07BX05 | 08.08. | B |
| 2 | 10 | Fertigspritze(n) | J07BX05 | 08.08. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is mResvia Respiratorisches-Synzytial-Virus (RSV) Vakzin 0.10 mg/ml authorised in Switzerland?
Yes. mResvia Respiratorisches-Synzytial-Virus (RSV) Vakzin 0.10 mg/ml is authorised by Swissmedic under authorisation number 69995, data as of 01 September 2026. The authorisation is limited until 16 April 2030.
Which dispensing category does mResvia Respiratorisches-Synzytial-Virus (RSV) Vakzin 0.10 mg/ml have?
mResvia Respiratorisches-Synzytial-Virus (RSV) Vakzin 0.10 mg/ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of mResvia Respiratorisches-Synzytial-Virus (RSV) Vakzin 0.10 mg/ml?
The authorisation holder is Moderna Switzerland GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.